Toolkit/next-generation sequencing
next-generation sequencing
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Multi-locus sequencing, multiplex PCR, and next-generation sequencing refined the identification of fungal and bacterial pathogens.
Usefulness & Problems
Why this is useful
Next-generation sequencing is described as refining identification of fungal and bacterial pathogens in chrysanthemum.; identification of fungal pathogens in chrysanthemum; identification of bacterial pathogens in chrysanthemum; NGS is described as an advanced tool that helps identify novel tumor-specific targets. The abstract also links it to improving therapy design.; identifying novel tumor-specific targets; improving therapy designs; The abstract lists next-generation sequencing as one of the latest technologies enabling sensitive tobamovirus detection and enhanced surveillance capabilities.; tobamovirus detection; surveillance
Source:
Next-generation sequencing is described as refining identification of fungal and bacterial pathogens in chrysanthemum.
Source:
identification of fungal pathogens in chrysanthemum
Source:
identification of bacterial pathogens in chrysanthemum
Source:
NGS is described as an advanced tool that helps identify novel tumor-specific targets. The abstract also links it to improving therapy design.
Source:
identifying novel tumor-specific targets
Source:
improving therapy designs
Source:
The abstract lists next-generation sequencing as one of the latest technologies enabling sensitive tobamovirus detection and enhanced surveillance capabilities.
Source:
tobamovirus detection
Source:
surveillance
Problem solved
It improves pathogen identification in chrysanthemum disease studies.; refines pathogen identification; insufficient target identification for improved CAR-T design; It contributes to surveillance and detection of emerging tobamoviruses.; supports sensitive detection and surveillance of tobamoviruses
Source:
It improves pathogen identification in chrysanthemum disease studies.
Source:
refines pathogen identification
Source:
insufficient target identification for improved CAR-T design
Source:
It contributes to surveillance and detection of emerging tobamoviruses.
Source:
supports sensitive detection and surveillance of tobamoviruses
Problem links
insufficient target identification for improved CAR-T design
LiteratureNGS is described as an advanced tool that helps identify novel tumor-specific targets. The abstract also links it to improving therapy design.
Source:
NGS is described as an advanced tool that helps identify novel tumor-specific targets. The abstract also links it to improving therapy design.
refines pathogen identification
LiteratureIt improves pathogen identification in chrysanthemum disease studies.
Source:
It improves pathogen identification in chrysanthemum disease studies.
supports sensitive detection and surveillance of tobamoviruses
LiteratureIt contributes to surveillance and detection of emerging tobamoviruses.
Source:
It contributes to surveillance and detection of emerging tobamoviruses.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Target processes
No target processes tagged yet.
Implementation Constraints
The abstract supports a sequencing-based identification role but does not provide platform, library-prep, or analysis details.; requires sequencing capability; The abstract does not specify sequencing platform, library preparation, or analysis requirements.
The abstract does not claim that next-generation sequencing itself controls disease or creates resistance.
Validation
Supporting Sources
Ranked Claims
Future sustainable chrysanthemum protection should integrate molecular breeding, genome editing, RNA-based tools, and microbiome management.
Multi-locus sequencing, multiplex PCR, and next-generation sequencing refined identification of fungal and bacterial pathogens in chrysanthemum research.
Approval Evidence
Sensitive detection of tobamoviruses in the field with minimal sample preparation can be achieved using latest technologies such as isothermal amplification, CRISPR/Cas-hybrid assays or next-generation sequencing.
Source:
advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs
Source:
Multi-locus sequencing, multiplex PCR, and next-generation sequencing refined the identification of fungal and bacterial pathogens.
Source:
advances in next-generation sequencing (NGS) and gene-editing technology have begun to close this gap
Source:
Isothermal amplification, CRISPR/Cas-hybrid assays, and next-generation sequencing can achieve sensitive detection of tobamoviruses in the field with minimal sample preparation.
Source:
Multi-locus sequencing, multiplex PCR, and next-generation sequencing refined identification of fungal and bacterial pathogens in chrysanthemum research.
Source:
NGS, dSTORM, and multiparametric flow cytometry help identify novel tumor-specific targets and improve CAR-T therapy designs.
advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs
Source:
Comparisons
Source-stated alternatives
The abstract mentions multi-locus sequencing and multiplex PCR as alternative identification approaches.; The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Source:
The abstract mentions multi-locus sequencing and multiplex PCR as alternative identification approaches.
Source:
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Source-backed strengths
presented as improving pathogen identification; presented as an advanced tool supporting target discovery; included among latest technologies that enhanced surveillance capabilities
Source:
presented as improving pathogen identification
Source:
presented as an advanced tool supporting target discovery
Source:
included among latest technologies that enhanced surveillance capabilities
Compared with assays
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as improving pathogen identification; presented as an advanced tool supporting target discovery; included among latest technologies that enhanced surveillance capabilities.
Source:
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Compared with CRISPR/Cas9
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as improving pathogen identification; presented as an advanced tool supporting target discovery; included among latest technologies that enhanced surveillance capabilities.
Source:
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Compared with CRISPR/Cas9 system
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as improving pathogen identification; presented as an advanced tool supporting target discovery; included among latest technologies that enhanced surveillance capabilities.
Source:
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Compared with CRISPR/Cas-hybrid assays
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as improving pathogen identification; presented as an advanced tool supporting target discovery; included among latest technologies that enhanced surveillance capabilities.
Source:
The abstract mentions isothermal amplification and CRISPR/Cas-hybrid assays as alternative diagnostic approaches.
Compared with multiplex PCR
The abstract mentions multi-locus sequencing and multiplex PCR as alternative identification approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as improving pathogen identification; presented as an advanced tool supporting target discovery; included among latest technologies that enhanced surveillance capabilities.
Source:
The abstract mentions multi-locus sequencing and multiplex PCR as alternative identification approaches.
Ranked Citations
- 1.